Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guopei Luo

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Cancer Management and Research|January 15, 2021
Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine NeoplasmsShengming Deng, Zhiyao Fan, Huanyu Xia, et al.
World Journal of Surgical Oncology|February 1, 2021
High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinomaYitao Gong, Yunzhen Qian, Guopei Luo, et al.
International Journal of Cancer|March 9, 2023
EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasmsZhiwen Xiao, Huaxiang Xu, Jonathan R Strosberg, et al.
International Journal of Molecular Sciences|January 6, 2017
Somatic Genetic Variation in Solid Pseudopapillary Tumor of the Pancreas by Whole Exome SequencingMeng Guo, Guopei Luo, Kaizhou Jin, et al.
Journal of Hematology & Oncology|February 2, 2018
Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directionsYiyin Zhang, Chao Yang, He Cheng, et al.
Acta Biochimica Et Biophysica Sinica|February 20, 2020
HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLRZhiyao Fan, Kun Fan, Shengming Deng, et al.
Cancer Letters|January 17, 2018
MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancerKun Fan, Chao Yang, Zhiyao Fan, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2018
Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinomaChao Yang, He Cheng, Yiyin Zhang, et al.
Annals of Surgery|March 8, 2017
Potential Biomarkers in Lewis Negative Patients With Pancreatic CancerGuopei Luo, Chen Liu, Meng Guo, et al.
Oncotarget|April 16, 2016
Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?Chen Liu, Yu Lu, Guopei Luo, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Cancer Management and Research|January 15, 2021
Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine NeoplasmsShengming Deng, Zhiyao Fan, Huanyu Xia, et al.
World Journal of Surgical Oncology|February 1, 2021
High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinomaYitao Gong, Yunzhen Qian, Guopei Luo, et al.
International Journal of Cancer|March 9, 2023
EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasmsZhiwen Xiao, Huaxiang Xu, Jonathan R Strosberg, et al.
International Journal of Molecular Sciences|January 6, 2017
Somatic Genetic Variation in Solid Pseudopapillary Tumor of the Pancreas by Whole Exome SequencingMeng Guo, Guopei Luo, Kaizhou Jin, et al.
Journal of Hematology & Oncology|February 2, 2018
Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directionsYiyin Zhang, Chao Yang, He Cheng, et al.
Acta Biochimica Et Biophysica Sinica|February 20, 2020
HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLRZhiyao Fan, Kun Fan, Shengming Deng, et al.
Cancer Letters|January 17, 2018
MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancerKun Fan, Chao Yang, Zhiyao Fan, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2018
Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinomaChao Yang, He Cheng, Yiyin Zhang, et al.
Annals of Surgery|March 8, 2017
Potential Biomarkers in Lewis Negative Patients With Pancreatic CancerGuopei Luo, Chen Liu, Meng Guo, et al.
Oncotarget|April 16, 2016
Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?Chen Liu, Yu Lu, Guopei Luo, et al.
Pageof 9